Detalles de la búsqueda
1.
Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer.
Future Oncol
; 18(12): 1485-1497, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114807
2.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451345
3.
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
Br J Cancer
; 122(9): 1324-1332, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32161368
4.
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.
Target Oncol
; 17(1): 1-13, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35020119
5.
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors.
JTO Clin Res Rep
; 2(9): 100206, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590052
6.
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
Front Oncol
; 11: 709877, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307179
7.
Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial.
Lung Cancer
; 147: 209-213, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738416
8.
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma.
Liver Cancer
; 7(2): 165-178, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29888206
Resultados
1 -
8
de 8
1
Próxima >
>>